ANTIVIRAL THERAPY, cilt.12, sa.5, ss.761-768, 2007 (SCI-Expanded)
Aims: This study was conducted to clarify the resistance profile of a novel mutation pattern emerging during lamivudine (3TC) therapy and showing cross-resistance to adefovir dipivoxil (ADV) in a patient with chronic hepatitis B.